Ontvang nu dagelijks onze kooptips!
word abonnee
sluiten ✕
Terug naar discussie overzicht
Eurocastle Februari 2013
Volgen
Het is vijf mnd geleden dat deze slotkoers op het scherm stond.
ja, dit is een doorbraakje mensen. Kerremelk, je bent bijna aan de beurt!
De verdubbeling sinds januari is een feit. Het zware blok op .06 is doorbroken en zo stil hier? Iedereen aan het feesten?
vastgoed zit terug in de lift en zeker in duitsland waar ect een grote inpak heeft
nou, ik feest nog even niet, ik heb ze wel gekocht voor gemiddeld onder 4 cent maar heb het al eens vaker een paar centen in de week zien vallen en dat kan dus ook.
inderdaad we zijn er nog niet maar ik heb er een goed gevoel bij.
Alle barrometrs staan positief plus dat we in een aanloop zitten voor de cijfers.
nou ik hoop dat iedereen hier grote successen mee behaald hoor en alle goede gevoelens uitkomen ;-)
mag niet te lang? mail verstuurd zondag, naar americano in NY (de staat) 1ste helft Gary, so sorry to hear about your breaking your toe. I must keep myself from thinking I was somehow a cause of your mishap. I don’t believe I was the sole cause, but, none-the-less.. perhaps one of the reasons you went over there. But that day, since I was not in any hurry, was not of my choosing. I am still in no hurry. I do have an enormous backlog. I hope the strained muscle has been rested and healed. You know I got in early Retirement on boxing day last December, and have since seen my income decrease, but.. I knew I can live fairly well on half of what my future monthly income will be. (and I can still squander some on my favorite hobbies..) Stock portfolio has taken an upturn. Took some losses in a BIO-tech (heavy losses, actually), and invested the released funds in an older acquantance, a fund that controls about 2.3 billion euro in German commercial real estate but was over-leveraged some years ago. Years ago, I made good profits on this fund, and I saw it at an all time low last november/december.. bought a good deal, and it’s made good so far. It’s been up over 60 percent for a while now (fibonacci trends to still better, underlying net value alone would be worth a hell of a lot more than I paid..), and the ticker will likely go to mean volume/price average it had for last year (it is still a ways under that) In short, if I sell half of What I invested in that fund, right now, I make good on losses I made in that biotech, and have 19.000 dollar profit on top of that. Other stock I divested in have risen some, still other took a 40 percent dive, but I was divested. The bio, it rose a bit after I sold, is now lower than when I sold. Dividend stock I kept long term have announced they will give much higher dividend this year.. and is now rising far too sharply (months before payout date) (an opportunity, with a window to sell on the head before next ex dividend low so, that one does not have to pay 45 percent taxes on dividend. Go figure.) It took me some years to learn when to take losses, but overall, (an excel sheet keeps tabs on all I ever had.. and still have) well, the entire folio I keep shows 45 percent profit on invested (after losses and gains, after trading cost and taxes..) This is BETTER than keeping it in a sock, and since banks savings accounts give next to nothing (less than inflation), it was better than letting all ride in the bank. In Belgium, an incredible amount is in savings accounts that earn less than inflation... People are still shunning stocks. Somebody said, buy while blood runs in the streets. Last year, I did. Took a loss on that bio, cashed in on a head (as in a a head shoulders graph) on an other (in a rise, when you do it..., to see the drop later..), and bought into that german stuff from panickers. (ECT, eurocastle, it's now a penny stock, I know it inside out. But, I read all the publications and prospectuses, and have done so for many many years, and will eventually keep about 1 percent of its stock for the FAR future (like 2020.. because I think it by then have gone up twentyfold.. They do not pay dividends now, their main focus is divesting of non leased buildings, lease out more, (not buy more), fix short term debt, and eventually, fix a long term obligation agreament with their own mother fund. (Fortress.. a hedge fund). All in all, in 2020 or so, the net asset value per outstanding share (in assumption all is settled) is likely to be 3 to 4 times higher than it is now. (now, at 59ct, it is 9 times current trade price (in assumption all is settled..) The difference then, 2019/2020 or so, is that, once they actually again pay dividends, the dividend may very well be (again) over 16 precent of NAV/share Now, over 5 percent of dividend on NAV/share, means 20/1, and usually means spikes each year. I fuly intend to be a winner, a real long term big time winner (as in, only invest with money I got from previous trade gains) Oh, I have two percent NOW. I intend to keep no more than 1 percent for long term.. may have to divest after august, buy back in nov/dec 2013, but after june 2014, it will be a whole other picture. (People will know about outstanding debts on a much better occupied part of their properties (called drive folio) (mars folio was troubled) because by Q3 of 2014, results of the renegotiated -or settled- for that key moment will have to be published..) June 2012, they showed profit on total, mostly from rent, some from sales. (and some for managing mars, a 75pct divested folio) Expected year result is march 2013 There is an expected bubble effect, a spike to 50 percent of current trading between 5 and 6. (mean support on 4ct, current trading still hits 5ct (stradles°), but 6ct gets bought fairly well as well) Once august is there, a decline could start, (depends on what march 22, 2013 means to stock holders).
tweede helft I expect it to hit a new low (nov/dec), and another slow climb for 2014 year result, and a bang (or fuff) in july 2014. (announcement of the outcome for much better doing folio renegotiation) (I expect a bang, and not a small one) By then, the troubled mars folio will be probably nearly completely divested (sold properties have shown profit 2011 and 2012), and the drive debt renegotiated, (together, they are 14 percent of the properties in ECT), so that drive (about 9 percent) will have a much less detrimental impact on outstanding debt vs total. Of course, with fewer properties, or lettable space, the brick and mortar assets value is less, but the debt also grew less -in greater proportion-, and the value of these properties, it has already showed better than value in the books. This is, imo, leverage. Once principal debt (and not only interest) gets lower (probably 2013), and even more so in 2014, the road to fully owned is open. Once convertible bond obligations to fortress are converted (most of deferred interest convertible bonds belong to to mother hedge fund, but ECT is not a hedge fund), the current left-pocket/right-pocket hokum (ECT gets a fee for managing the troubled mars assets) will finally end, and the neat thing here.. The neat thing is that all these convertibles are already shown when they report NAV (net asset value)/share (they show 59 cent per share, over 645 Million (theoretical) shares. -- NAV is not (rightly so) shown over only 129 million shares which are currently out in market--- So, in the assumption that, after all troubles are behind the lettable space in ECT, the building management company, and they have a robust debt/ownd ratio (it ain’t too bad.. even NOW ), the NAV further drops to 46 cent (my crystal calculator), it still means an huge undervalue compared to current trading price. (short term supprt 4ct, mean is 5 ct, upward trending with resistance on 6) 6 month fibonacci, indicates, into 6 ct mean, resistance 8 My short term? Current, one can still buy at 5(with much patience), but in the last three weeks there were/are serious buyers at 6.. Resistance at 6? Sure I expect some 14 million will be bought/sold before march 22nd. (2012 year result) Probably mostly still in the 6ct range, but with spikes to 7, and maybe some 6 million will sell at 7 Then, weeks later, maybe april to june, we may see peaks to 9 and so on, but on much lower volumes. (first quarter results in may will trigger some) (there is a june 2013 trigger on some cdo) And then, The BIG Question. Higher still? (NOBODY KNOWS) Depending on outcome of mars folio negotiation, once we are in august, some convertibles may convert, (could be renegotiated). However.. Once they (already converted/newly converted) start “dumping”, the small penny stock players will scuttle. That’s why I expect that by nov/dec 2013, they will be again at the 2012 low (and next opportunity to get in big time is again there) jt
ik schrijf net zo onsamenhangend in 't engels dan in ' vlaams? Zo hier en daar vind ik lacunes, of niet geschreven gedachte treintjes, mss zijn mijn schrijfsels echt de chaos waardig. In elk geval, met 5.5x mio aan 6ct gisteren, met bijna (only) 5000 stuks aan 5ct gisteren, en een prikje naar 7 ct van 102000 (belange geen doorbraak), was ik in dat mailtje naar Gary nogal "voorzichtig" of niet? JT Oh ja, kokosvrucht gemalen met nog iets..Ik heb het nog nooit geproeft. En Dat is klappermelk? het liedje is niet mis (oubollig)
Moguh heren en enkele dame, Vele dagorders geweest zie ik van gisteren....hopen dat de bied weer wat gaat toenemen en dan graag in doorlooporders!! Neem gewoon het risico dat we naar de .10 gaan.
Begrijpelijk dat er aandeelhouders die gekocht hebben rond de 0,03/0,04 nu winst pakken. Ik vind het alleen jammer dat ik daar niet bij zit. Nu is het ook weer zo dat ongeveer een miljoen uit de bied is gehaald en het dus lijkt of er veel verkocht is, maar dat is slechts schijn. Verwacht dat die bieders snel terug zijn. Het winstnemen houd de stijging van de koers namelijk niet tegen, maat stimuleert deze juist.
Bovendien was het wel makkelijk om op 0,06 te verkopen, maar om ze nu nog voor 0,06 te kopen word al lastiger gezien wat er aangeboden word.
Klopt Lucas.... En op bloedrode beursdagen gaan beleggers op zoek naar de lagere noteringen, en aangezien wij bij het eurokasteel weinig tot niets te maken hebben met het aex,amx,ascx sentiment....kan het nog een leuke week worden.
staat al weer meer dan 2,5 miljoen in de bied op 6 cent
nu gaarne nog een kleine verkoop van 31500 stukkies (dan zit ik vol) en dan verder up!!
ch@rter schreef op 21 februari 2013 10:19 :
Moguh heren en enkele dame,
Vele dagorders geweest zie ik van gisteren....hopen dat de bied weer wat gaat toenemen en dan graag in doorlooporders!! Neem gewoon het risico dat we naar de .10 gaan.
Zeer mooie bied weer op de .06 (zet ze maar op doorloop om nog kans te maken zo goedkoop in te stappen!!
De huidige koers is een typisch gevalletje van niet zeker weten of je het goed doet. Als je het boekje bekijkt en interpreteerd dan kan deze koers nog wel een week hetzelfde zijn, en zeker niet lager. Wat ook kan is dat de koers plotsklaps op 0,08 gezet kan worden en daarna langzaam doorstijgt. Ik kies uiteraard voor dat laatste scenario, maar ik ben licht bevoordeeld omdat ik al aandelen heb.:~) Noot:Mijn Bammetjes doen het wat minder, maar Imtech is deze week mijn winstmaker.
Aantal posts per pagina:
20
50
100
Direct naar Forum
-- Selecteer een forum --
Koffiekamer
Belastingzaken
Beleggingsfondsen
Beursspel
BioPharma
Daytraders
Garantieproducten
Opties
Technische Analyse
Technische Analyse Software
Vastgoed
Warrants
10 van Tak
4Energy Invest
Aalberts
AB InBev
Abionyx Pharma
Ablynx
ABN AMRO
ABO-Group
Acacia Pharma
Accell Group
Accentis
Accsys Technologies
ACCSYS TECHNOLOGIES PLC
Ackermans & van Haaren
ADMA Biologics
Adomos
AdUX
Adyen
Aedifica
Aegon
AFC Ajax
Affimed NV
ageas
Agfa-Gevaert
Ahold
Air France - KLM
AIRBUS
Airspray
Akka Technologies
AkzoNobel
Alfen
Allfunds Group
Allfunds Group
Almunda Professionals (vh Novisource)
Alpha Pro Tech
Alphabet Inc.
Altice
Alumexx ((Voorheen Phelix (voorheen Inverko))
AM
Amarin Corporation
Amerikaanse aandelen
AMG
AMS
Amsterdam Commodities
AMT Holding
Anavex Life Sciences Corp
Antonov
Aperam
Apollo Alternative Assets
Apple
Arcadis
Arcelor Mittal
Archos
Arcona Property Fund
arGEN-X
Aroundtown SA
Arrowhead Research
Ascencio
ASIT biotech
ASMI
ASML
ASR Nederland
ATAI Life Sciences
Atenor Group
Athlon Group
Atrium European Real Estate
Auplata
Avantium
Axsome Therapeutics
Azelis Group
Azerion
B&S Group
Baan
Ballast Nedam
BALTA GROUP N.V.
BAM Groep
Banco de Sabadell
Banimmo A
Barco
Barrick Gold
BASF SE
Basic-Fit
Basilix
Batenburg Beheer
BE Semiconductor
Beaulieulaan
Befimmo
Bekaert
Belgische aandelen
Beluga
Beter Bed
Bever
Binck
Biocartis
Biophytis
Biosynex
Biotalys
Bitcoin en andere cryptocurrencies
bluebird bio
Blydenstijn-Willink
BMW
BNP Paribas S.A.
Boeing Company
Bols (Lucas Bols N.V.)
Bone Therapeutics
Borr Drilling
Boskalis
BP PLC
bpost
Brand Funding
Brederode
Brill
Bristol-Myers Squibb
Brunel
C/Tac
Campine
Canadese aandelen
Care Property Invest
Carmila
Carrefour
Cate, ten
CECONOMY
Celyad
CFD's
CFE
CGG
Chinese aandelen
Cibox Interactive
Citygroup
Claranova
CM.com
Co.Br.Ha.
Coca-Cola European Partners
Cofinimmo
Cognosec
Colruyt
Commerzbank
Compagnie des Alpes
Compagnie du Bois Sauvage
Connect Group
Continental AG
Corbion
Core Labs
Corporate Express
Corus
Crescent (voorheen Option)
Crown van Gelder
Crucell
CTP
Curetis
CV-meter
CVC Capital Partners
Cyber Security 1 AB
Cybergun
D'Ieteren
D.E Master Blenders 1753
Deceuninck
Delta Lloyd
DEME
Deutsche Cannabis
DEUTSCHE POST AG
Dexia
DGB Group
DIA
Diegem Kennedy
Distri-Land Certificate
DNC
Dockwise
DPA Flex Group
Draka Holding
DSC2
DSM
Duitse aandelen
Dutch Star Companies ONE
Duurzaam Beleggen
DVRG
Ease2pay
Ebusco
Eckert-Ziegler
Econocom Group
Econosto
Edelmetalen
Ekopak
Elastic N.V.
Elia
Endemol
Energie
Energiekontor
Engie
Envipco
Erasmus Beursspel
Eriks
Esperite (voorheen Cryo Save)
EUR/USD
Eurobio
Eurocastle
Eurocommercial Properties
Euronav
Euronext
Euronext
Euronext.liffe Optiecompetitie
Europcar Mobility Group
Europlasma
EVC
EVS Broadcast Equipment
Exact
Exmar
Exor
Facebook
Fagron
Fastned
Fingerprint Cards AB
First Solar Inc
FlatexDeGiro
Floridienne
Flow Traders
Fluxys Belgium D
FNG (voorheen DICO International)
Fondsmanager Gezocht
ForFarmers
Fountain
Frans Maas
Franse aandelen
FuelCell Energy
Fugro
Futures
FX, Forex, foreign exchange market, valutamarkt
Galapagos
Gamma
Gaussin
GBL
Gemalto
General Electric
Genfit
Genmab
GeoJunxion
Getronics
Gilead Sciences
Gimv
Global Graphics
Goud
GrandVision
Great Panther Mining
Greenyard
Grolsch
Grondstoffen
Grontmij
Guru
Hagemeyer
HAL
Hamon Groep
Hedge funds: Haaien of helden?
Heijmans
Heineken
Hello Fresh
HES Beheer
Hitt
Holland Colours
Homburg Invest
Home Invest Belgium
Hoop Effektenbank, v.d.
Hunter Douglas
Hydratec Industries (v/h Nyloplast)
HyGear (NPEX effectenbeurs)
HYLORIS
Hypotheken
IBA
ICT Automatisering
Iep Invest (voorheen Punch International)
Ierse aandelen
IEX Group
IEX.nl Sparen
IMCD
Immo Moury
Immobel
Imtech
ING Groep
Innoconcepts
InPost
Insmed Incorporated (INSM)
IntegraGen
Intel
Intertrust
Intervest Offices & Warehouses
Intrasense
InVivo Therapeutics Holdings Corp (NVIV)
Isotis
JDE PEET'S
Jensen-Group
Jetix Europe
Johnson & Johnson
Just Eat Takeaway
Kardan
Kas Bank
KBC Ancora
KBC Groep
Kendrion
Keyware Technologies
Kiadis Pharma
Kinepolis Group
KKO International
Klépierre
KPN
KPNQwest
KUKA AG
La Jolla Pharmaceutical
Lavide Holding (voorheen Qurius)
LBC
LBI International
Leasinvest
Logica
Lotus Bakeries
Macintosh Retail Group
Majorel
Marel
Mastrad
Materialise NV
McGregor
MDxHealth
Mediq
Melexis
Merus Labs International
Merus NV
Microsoft
Miko
Mithra Pharmaceuticals
Montea
Moolen, van der
Mopoli
Morefield Group
Mota-Engil Africa
MotorK
Moury Construct
MTY Holdings (voorheen Alanheri)
Nationale Bank van België
Nationale Nederlanden
NBZ
Nedap
Nedfield
Nedschroef
Nedsense Enterpr
Nel ASA
Neoen SA
Neopost
Neovacs
NEPI Rockcastle
Netflix
New Sources Energy
Neways Electronics
NewTree
NexTech AR Solutions
Nextensa
NIBC
Nieuwe Steen Investments
Nintendo
Nokia
Nokia Oyj
Nokia OYJ
Novacyt
NOVO-NORDISK AS
NPEX
NR21
Numico
Nutreco
Nvidia
NWE Nederlandse AM Hypotheek Bank
NX Filtration
NXP Semiconductors NV
Nyrstar
Nyxoah
Océ
OCI
Octoplus
Oil States International
Onconova Therapeutics
Ontex
Onward Medical
Onxeo SA
OpenTV
OpGen
Opinies - Tilburg Trading Club
Opportunty Investment Management
Orange Belgium
Oranjewoud
Ordina Beheer
Oud ForFarmers
Oxurion (vh ThromboGenics)
P&O Nedlloyd
PAVmed
Payton Planar Magnetics
Perpetuals, Steepeners
Pershing Square Holdings Ltd
Personalized Nursing Services
Pfizer
Pharco
Pharming
Pharnext
Philips
Picanol
Pieris Pharmaceuticals
Plug Power
Politiek
Porceleyne Fles
Portugese aandelen
PostNL
Priority Telecom
Prologis Euro Prop
ProQR Therapeutics
PROSIEBENSAT.1 MEDIA SE
Prosus
Proximus
Qrf
Qualcomm
Quest For Growth
Rabobank Certificaat
Randstad
Range Beleggen
Recticel
Reed Elsevier
Reesink
Refresco Gerber
Reibel
Relief therapeutics
Renewi
Rente en valuta
Resilux
Retail Estates
RoodMicrotec
Roularta Media
Royal Bank Of Scotland
Royal Dutch Shell
RTL Group
RTL Group
S&P 500
Samas Groep
Sapec
SBM Offshore
Scandinavische (Noorse, Zweedse, Deense, Finse) aandelen
Schuitema
Seagull
Sequana Medical
Shurgard
Siemens Gamesa
Sif Holding
Signify
Simac
Sioen Industries
Sipef
Sligro Food Group
SMA Solar technology
Smartphoto Group
Smit Internationale
Snowworld
SNS Fundcoach Beleggingsfondsen Competitie
SNS Reaal
SNS Small & Midcap Competitie
Sofina
Softimat
Solocal Group
Solvac
Solvay
Sopheon
Spadel
Sparen voor later
Spectra7 Microsystems
Spotify
Spyker N.V.
Stellantis
Stellantis
Stern
Stork
Sucraf A en B
Sunrun
Super de Boer
SVK (Scheerders van Kerchove)
Syensqo
Systeem Trading
Taiwan Semiconductor Manufacturing Company (TSMC)
Technicolor
Tele Atlas
Telegraaf Media
Telenet Groep Holding
Tencent Holdings Ltd
Tesla Motors Inc.
Tessenderlo Group
Tetragon Financial Group
Teva Pharmaceutical Industries
Texaf
Theon International
TherapeuticsMD
Thunderbird Resorts
TIE
Tigenix
Tikkurila
TINC
TITAN CEMENT INTERNATIONAL
TKH Group
TMC
TNT Express
TomTom
Transocean
Trigano
Tubize
Turbo's
Twilio
UCB
Umicore
Unibail-Rodamco
Unifiedpost
Unilever
Unilever
uniQure
Unit 4 Agresso
Univar
Universal Music Group
USG People
Vallourec
Value8
Value8 Cum Pref
Van de Velde
Van Lanschot
Vastned
Vastned Retail Belgium
Vedior
VendexKBB
VEON
Vermogensbeheer
Versatel
VESTAS WIND SYSTEMS
VGP
Via Net.Works
Viohalco
Vivendi
Vivoryon Therapeutics
VNU
VolkerWessels
Volkswagen
Volta Finance
Vonovia
Vopak
Warehouses
Wave Life Sciences Ltd
Wavin
WDP
Wegener
Weibo Corp
Wereldhave
Wereldhave Belgium
Wessanen
What's Cooking
Wolters Kluwer
X-FAB
Xebec
Xeikon
Xior
Yatra Capital Limited
Zalando
Zenitel
Zénobe Gramme
Ziggo
Zilver - Silver World Spot (USD)
Premium
Word nu abonnee van IEX en krijg onbeperkt toegang tot onze (koop)tips en succesvolle modelportefeuilles. Nu 3 maanden voor slechts €19,95! Profiteer van 58% korting!
Word abonnee